Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 1
2017 2
2019 2
2020 1
2021 2
2022 5
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
The circadian clock circuitry modulates leukemia initiating cell activity in T-cell acute lymphoblastic leukemia.
Murgo E, De Santis E, Sansico F, Melocchi V, Colangelo T, Padovano C, Colucci M, Carbone A, Totti B, Basti A, Gottschlich L, Relogio A, Capitanio N, Bianchi F, Mazzoccoli G, Giambra V. Murgo E, et al. Among authors: melocchi v. J Exp Clin Cancer Res. 2023 Aug 24;42(1):218. doi: 10.1186/s13046-023-02799-7. J Exp Clin Cancer Res. 2023. PMID: 37620852 Free PMC article.
miRNome profiling of lung cancer metastases revealed a key role for miRNA-PD-L1 axis in the modulation of chemotherapy response.
Cuttano R, Colangelo T, Guarize J, Dama E, Cocomazzi MP, Mazzarelli F, Melocchi V, Palumbo O, Marino E, Belloni E, Montani F, Vecchi M, Barberis M, Graziano P, Pasquier A, Sanz-Ortega J, Montuenga LM, Carbonelli C, Spaggiari L, Bianchi F. Cuttano R, et al. Among authors: melocchi v. J Hematol Oncol. 2022 Dec 31;15(1):178. doi: 10.1186/s13045-022-01394-1. J Hematol Oncol. 2022. PMID: 36587234 Free PMC article.
FMRP modulates the Wnt signalling pathway in glioblastoma.
Pedini G, Buccarelli M, Bianchi F, Pacini L, Cencelli G, D'Alessandris QG, Martini M, Giannetti S, Sasso F, Melocchi V, Farace MG, Achsel T, Larocca LM, Ricci-Vitiani L, Pallini R, Bagni C. Pedini G, et al. Among authors: melocchi v. Cell Death Dis. 2022 Aug 18;13(8):719. doi: 10.1038/s41419-022-05019-w. Cell Death Dis. 2022. PMID: 35982038 Free PMC article.
An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasms.
Pelosi G, Melocchi V, Dama E, Hofman P, De Luca M, Albini A, Gemelli M, Ricotta R, Papotti M, La Rosa S, Uccella S, Harari S, Sonzogni A, Asiedu MK, Wigle DA, Bianchi F. Pelosi G, et al. Among authors: melocchi v. Exp Mol Pathol. 2024 Feb;135:104882. doi: 10.1016/j.yexmp.2024.104882. Epub 2024 Jan 20. Exp Mol Pathol. 2024. PMID: 38237798 Free article.
Combined analysis of miR-200 family and its significance for breast cancer.
Fontana A, Barbano R, Dama E, Pasculli B, Rendina M, Morritti MG, Melocchi V, Castelvetere M, Valori VM, Ravaioli S, Bravaccini S, Ciuffreda L, Graziano P, Maiello E, Copetti M, Fazio VM, Esteller M, Bianchi F, Parrella P. Fontana A, et al. Among authors: melocchi v. Sci Rep. 2021 Feb 3;11(1):2980. doi: 10.1038/s41598-021-82286-1. Sci Rep. 2021. PMID: 33536459 Free PMC article.
Integrated molecular profiling of patient-derived ovarian cancer models identifies clinically relevant signatures and tumor vulnerabilities.
Lupia M, Melocchi V, Bizzaro F, Lo Riso P, Dama E, Baronio M, Ranghiero A, Barberis M, Bernard L, Bertalot G, Giavazzi R, Testa G, Bianchi F, Cavallaro U. Lupia M, et al. Among authors: melocchi v. Int J Cancer. 2022 Jul 15;151(2):240-254. doi: 10.1002/ijc.33983. Epub 2022 Mar 14. Int J Cancer. 2022. PMID: 35218560 Free PMC article.
16 results